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Primary non-Hodgkin’s lymphoma of the ovary is a rare occurrence. An ovarian involvement by non-Hodgkin
lymphoma (NHL) may include one of the four subtypes of lymphoma: diffuse large B-cell lymphoma, Burkitt’s
lymphoma (BL), lymphoblastic lymphoma or anaplastic large cell lymphoma. Burkitt’s lymphoma is a rare entity
with a specific poorly differentiated pattern.
Most women experience an ovarian BL with abdominal pelvic pain, abnormal vaginal bleeding, bowel obstruction,
urinary frequency, incontinence and abdominal mass. Sometimes these warning signs may be absent, causing a
late and more difficult diagnosis.
Here we report a case of a primary ovarian Burkitt’s lymphoma with bilateral involvement in a 57 year old patient.
She firstly presented neurological symptoms in the upper limbs and she was treated with surgery and combined
chemotherapy. The diagnosis of malignant lymphoma was established after bilateral adnexectomy and histological
study of the excised tissue.
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A 57-year-old pluriparous woman from Pakistan was ad-
mitted to the emergency ward due to a rapidly progres-
sive weakness in her arms, bilateral hypoaesthesia of the
1st, 2nd and 3rd finger and wide-spread pain in her
arms, shoulders and neck. Her medical history shows a
TBC infection at the age of 17. MRI revealed volumetric
increase of right C5-C6-C7 and left C6-C7 nerve roots
with a mild contrast enhancement as idiopathic neuritis.
Rachicentesis was negative. Serological HIV, HBV, HCV,
neurotropic virus tests and autoantibodies were negative.
The hematologic findings showed a low lymphocyte
count and a slight increase in neutrophils.
A Computer Tomography (CT) scan revealed multiple
enlarged lymph nodes involving the bilateral supracla-
vicular, left laterocervical, left and right paratracheal,
prevascular, aortopulmonary, left and right hilar and
subcarinal groups (Figure 1).* Correspondence: valentinagiovanale@libero.it
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reproduction in any medium, provided the orIn the pelvic cavity there was a solid inhomogeneous
mass, with necrotic areas (Figure 2).
The patient was transferred to the gynaecological ward
for a suspected adnexal neoplasia.
Further investigation showed high tumour markers with
CEA level of 3,3 ng/ml and Ca 19.9 level of 81,2 UI/ml;
Ca 125, α-fetoprotein and β-HCG were negative. Serum
immunofixation was negative for monoclonal components.
Vaginal ultrasound confirmed the presence of a left
ovarian mass; it measured 88 mm. There was no free
fluid in the abdominal cavity.
A bone marrow biopsy and aspiration were performed,
molecular evaluation showed a polyclonal rearrangement
of the IgH gene.
The patient underwent a laparotomic bilateral annessi-
ectomy; operative time length and mean haemoglobin
drop value results were 60 min and 125 ml respectively.
No adhesions of tumors and other organs, no intra-
operative and post-operative complications were observed.
Cytological examination of the peritoneal washing was
negative for neoplastic cells.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT scan of mediastinum-axial section. CT scan of mediastinum shows diffuse lymphatic swelling (arrow) over right supraclavicular
(A), pre-vascular (B-D) and aortopulmonary (C) station with inhomogeneous enhancing after contrast media, suggestive for lymphoma.
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B-cell ovarian lymphoma.
Immunohistochemical evaluation revealed the pres-
ence of tumour cells that were positive for B-cell
markers with a high proliferation rate (CD20, CD10 and
CD79a) (Figure 3 and 4).
The FISH test was negative for c-myc t (8;14) transloca-
tion and PCR was negative for t (14;18) translocation.
These patterns indicated a not translocated Burkitt's
lymphoma.Figure 2 Pelvic CT scan-axial and coronal sections. CT scan of pelvis in
neoformation 65x51x88mm in correspondence of left ovary, with multiple
administration. Figure 2B shows a vascular pedicle (white arrow) in the infeAccording to Ann Arbor Staging a diagnosis of stage IV
A was confirmed. After surgical resection the patient was
treated with an intensive G-mall chemotherapy protocol. In
older patient (> 55 years) G-m all protocol contemplates a
pre-phase of 5 days (cyclophosphamide 200 mg/m2 iv and
prednisone 60 mg/m2 ), cycle A1 from day 7, cycle A2 from
day 49 and a cycle A3 from day 98 (rituximab 375 mg/m2
iv, dexamethasone 10 mg/m2 po , methotrexate 500 mg/m2
iv and 12 mg i.th., ifosfamide 400 mg/m2 iv, cytarabine 2x60
mg/m2 iv, VP16 60 mg/m2 iv), cycle B1 from day 28, cyclearterial (A) and portal (B-C) phase, shows an inhomogeneous
necrotic areas within and a slow-enhancing after contrastum media
rior portion of the lesion rising from left ovarian artery.
Figure 3 Histological examination of ovarian lymphoma. Hematoxylin and eosin-stained sections (original magnifications X20, X100 and
X400) show a lymphoid proliferation of small B-cells with a widely monotonous growth pattern, suggestive for high-grade B-cell lymphoma.
The round nuclei have finely clumped and dispersed chromatin with multiple basophilic medium size nucleoli, often located in paracentral side.
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375 mg/m2 iv, dexamethasone 10 mg/m2 po, vincris-
tine 1mg iv, methotrexate 500 mg/m2 iv and 12 mg i.th.,
ciclofosfamide 200 mg/m2 iv, adriamicina 25 mg/m2 iv).
Post-operatively and post-CHT CT scan showed a
volumetric reduction of the enlarged lymph nodes.
Nevertheless the patient decided to sign her dischargeFigure 4 Immunohistochemical pattern. The slides show neoplastic B-ce
mitotic index of the lymphoma is very high with a Ki67 that is approssimatpapers, despite her poor physical condition and against
the advice of her doctors.
Discussion
Burkitt’s lymphoma (BL) is a highly aggressive, mature
B-cell lymphoma that shows an extremely rapid growth
rate [1,2]. In 2008, the World Health Organizationll CD20, CD79a (B cell associated antigen) and CD10 positive. The
ely equal to 100.
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of BL: African or endemic, sporadic and immunodefi-
ciency associated. Burkitt’s lymphoma of the ovaries can
be primary or more frequently secondary to a systemic
neoplastic process [3]. The ovary is often a site of sec-
ondary lymphomatous diffusion but less than 10% of
ovarian lymphomas have their onset in the ovary [2].
The secondary involvement may be an initial clinical
presentation of occult extra-ovarian disease or a mani-
festation of widely disseminated disease [4].
Primary ovarian lymphoma (POL) is an event that ac-
counts for 0.5% of NHL and 1.5% of all ovarian neopla-
sia, usually bilateral and often associated with ascites
[4-6].
In 1976, POL was defined by Fox and Langley with the
following criteria [6]:
(a) the disease has to be confined to the ovary,
(b) absence of disease in the blood and bone marrow,
(c) the extraovarian deposits, if any, should appear
at least after few months.
The most frequent clinical symptoms of gynaecologic
BL are pelvic pain, abnormal vaginal bleeding, bowel ob-
struction and abdominal mass with a rapid growth;
sometimes it shows unspecified symptoms with a more
difficult differential diagnosis [7]. Burkitt’s lymphoma is
generally defined as a neoplasia with a typical, but not
pathognomonic aspect of starry-sky pattern induced by
mitotes of macrophages, with neoplastic cells that tend
to form pseudoacini, structured in cords and nests. In
our case the clinical presentation of lymphoma did not
appear with the classical symptoms (fever, night sweats
and weight loss) since the patient referred to the hospital
manifesting the occurrence of hypoaestesia and weak-
ness of both the upper limbs. After a MRI evaluation
that identified a neurological compression of the cervical
nerve roots by multiple lymphoadenopathy, a CT scan
was performed and showed an adnexal mass. After sur-
gical removal the histological, molecular and cytogenetic
features indicated a not translocated Burkitt’s lymphoma.
According to the WHO classification up to 10% of BL
cases may lack a MYC translocation, nevertheless MYC
has a not specific involvement in BL [8].
Medical studies suggest that the origin of lymphomas in
the ovaries is associated with the presence of preexisting
lymphoid tissue in the ovary. Nevertheless other authors
reveal that reactive lymphocytes may secondarily involve
the ovary in response to inflammation (PID, endometriosis)
or autoimmune diseases and then they may undergo ma-
lignant change and give rise to POL [5,6]. The medical lit-
erature suggests that Burkitt’s lymphoma has to be
considered in an adult woman with an ovarian mass, ex-
cluding granulose tumours , granulocytic sarcoma, poorlydifferentiated carcinoma, metastasis and epithelial ovarian
neoplasia [3]. Being aware of the clinical impact of this
potentially curable lymphoma, our case showed the im-
portance of a detailed evaluation and multidisciplinary
collaboration.
The prognosis of our patient, according to the Inter-
national Prognostic Index of non-Hodgkin’s lymphoma,
is a 5-year survival of 43%, corresponding to an high-
intermediate risk [9]. The International Prognostic
Index (IPI) is a clinical tool used to predict the prog-
nosis of patients with aggressive non-Hodgkin's lymph-
oma. For the evaluation of the prognosis this clinical
score considers Ann Arbor staging, age, elevated
serum lactate dehydrogenase (LDH), performance sta-
tus, and number of extranodal sites of disease.
Written informed consent was obtained from the pa-
tient for publication of this Case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
The patient of our case gave her consent concerning
the case report.
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